Paychex, Inc. (LON:0KGE)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Market Capitalization	37,895	42,208	33,994	30,536	35,484	25,654
Market Cap Growth	24.16%	24.16%	11.32%	-13.94%	38.32%	22.12%
Enterprise Value	40,448	41,661	33,317	29,983	35,113	25,588
Last Close Price	105.80	115.97	90.79	79.76	89.46	63.31
PE Ratio	30.81	34.32	25.59	24.29	32.10	33.21
PS Ratio	9.17	10.21	8.20	7.55	9.69	8.98
PB Ratio	12.37	13.78	11.38	10.83	14.49	12.36
P/TBV Ratio	-	-	25.09	25.70	43.44	42.80
P/FCF Ratio	29.88	33.28	24.91	24.20	30.71	31.92
P/OCF Ratio	26.86	29.92	22.79	22.17	28.12	28.92
EV/Sales Ratio	9.62	10.08	8.03	7.42	9.59	8.96
EV/EBITDA Ratio	20.84	22.11	18.03	16.81	21.77	22.00
EV/EBIT Ratio	23.00	24.10	19.50	18.27	24.04	24.89
EV/FCF Ratio	31.89	32.85	24.42	23.76	30.39	31.84
Debt / Equity Ratio	1.22	1.22	0.23	0.25	0.29	0.31
Debt / EBITDA Ratio	1.96	1.96	0.37	0.40	0.44	0.55
Debt / FCF Ratio	2.95	2.95	0.51	0.57	0.62	0.81
Asset Turnover	0.41	0.41	0.50	0.50	0.49	0.46
Quick Ratio	0.52	0.52	0.59	0.52	0.48	0.42
Current Ratio	1.28	1.28	1.37	1.30	1.25	1.25
Return on Equity (ROE)	41.80%	41.80%	46.35%	47.35%	46.17%	38.31%
Return on Assets (ROA)	10.80%	10.80%	12.98%	12.59%	12.19%	10.27%
Return on Capital (ROIC)	21.01%	21.01%	29.98%	30.36%	29.24%	24.05%
Return on Capital Employed (ROCE)	24.20%	24.20%	42.80%	42.90%	42.10%	34.10%
Earnings Yield	3.25%	2.91%	3.91%	4.12%	3.12%	3.01%
FCF Yield	3.35%	3.00%	4.01%	4.13%	3.26%	3.13%
Dividend Yield	2.26%	2.57%	3.16%	3.30%	2.46%	2.80%
Payout Ratio	87.40%	87.40%	77.81%	75.45%	71.77%	82.80%
Buyback Yield / Dilution	0.03%	0.03%	0.06%	0.22%	-0.28%	-0.30%
Total Shareholder Return	2.28%	2.60%	3.21%	3.52%	2.18%	2.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.